Steven Blausey
Optometrist · Newark, OHNPI 1740294198
Payments from drug & device makers
Across 92 payments — averaging $107.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bausch & Lomb, A Division Of Bausch Health US, LLC$7K
- Bausch & Lomb Americas Inc.$816
- Tarsus Pharmaceuticals, Inc.$455
- AbbVie$375
- Oyster Point Pharma, Inc.$298
- Novartis$226
- plus $1K from 12 others
What the payments were for
- Speaking & faculty fees$6,50065%
- Food & beverage$3,40834%
- Education$180%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 4 | $6,683 |
| Bausch & Lomb Americas Inc. | 13 | $816 |
| Tarsus Pharmaceuticals, Inc. | 14 | $455 |
| AbbVie(2 entities) | 12 | $375 |
| Oyster Point Pharma, Inc. | 5 | $298 |
| Novartis | 12 | $226 |
| Alcon | 4 | $175 |
| Coopervision Inc. | 2 | $156 |
| Sun Pharmaceutical Industries Inc. | 7 | $154 |
| Dompe US, Inc. | 2 | $149 |
| Apellis Pharmaceuticals, Inc. | 2 | $138 |
| Astellas Pharma US Inc | 3 | $62 |
| Johnson & Johnson Vision Care, Inc. | 1 | $59 |
| Kala Pharmaceuticals, Inc. | 3 | $56 |
| Shire North American Group Inc | 4 | $51 |
| Biotissue Holdings Inc. | 2 | $44 |
| Glaukos Corporation | 1 | $15 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,926 in reported general payments places this provider in the 95th percentile of 1,995 optometrist providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LumiganBimatoprost | 12 | $5,826 |
| Prednisolone Acetate | 75 | $2,233 |
| Fluorometholone | 14 | $1,166 |
| Latanoprost | 100 | $998 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 60 | $803 |
| Diclofenac Sodium | 38 | $467 |
| Timolol Maleate | 23 | $380 |
| Brimonidine Tartrate | 57 | $332 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 25 | $65 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLumigan | $375 | $5,82612 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,995 optometrist providers in Ohio.
Other optometrist in Newark
- Katherine BickleGranville$3M
- Jennifer FogtColumbus$1.9M
- Jason MillerPowell$1.4M
- Mile BrujicBowling Green$1.3M
- William LayWesterville$891K
- Gregory DenaeyerColumbus$846K
- Thomas ChesterCleveland$786K
- Loretta Szczotka-FlynnCleveland$388K
- Cory LappinMontgomery$367K
- Dustin GardnerMarysville$314K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.